Bacteria in skin infections and noses of people with scabies or eczema
Looks at which bacteria infect the skin and nose in scabies or atopic dermatitis.
Plain-language title generated from the registry record
Registry title: Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis
Key facts
- Where
- Istanbul, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with scabies or atopic dermatitis who have an infected skin sore (impetigo). It also takes healthy people without skin disease to give nose swabs for comparison.
- Sex
- All sexes can join.
- Disease stage
- Scabies or atopic dermatitis confirmed by a skin doctor, with an active impetiginized (infected) skin lesion. The healthy group has no inflammatory skin disease and no signs of infection.
- Earlier treatment
- Cannot have used antibiotics, by mouth or on the skin, in the previous 14 days.
Main reasons for not taking part
- Antibiotic use (by mouth or on the skin) within the previous 14 days
- Active nasal infection or nasal symptoms
- History of nasal surgery
- Anatomic nasal deformity
Read by machine on 13 November 2026.
Where in Türkiye
- Test Study Site - ReplaceIstanbul, TürkiyeNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Istanbul Medeniyet University
- Trial code
- NCT07813611
- Record updated
- 15 September 2026
- Original description
This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasal colonization in participants with scabies or atopic dermatitis. Bacteria isolated from impetiginized skin lesions and nasal swabs will be compared, and antimicrobial susceptibility patterns will be assessed. Healthy participants without an inflammatory skin disease or signs of infection will provide nasal swabs as a control group. Patients will be followed on days 7 and 14 to assess clinical response and related clinical measures.Read full original descriptionShow less
Microbiological Profile of Secondary Bacterial Infections and Nasal Colonization in Patients With Scabies and Atopic Dermatitis: A Prospective Observational Study
This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasal colonization in participants with scabies or atopic dermatitis. Bacteria isolated from impetiginized skin lesions and nasal swabs will be compared, and antimicrobial susceptibility patterns will be assessed. Healthy participants without an inflammatory skin disease or signs of infection will provide nasal swabs as a control group. Patients will be followed on days 7 and 14 to assess clinical response and related clinical measures.
Inclusion: Scabies group: dermatologist-confirmed scabies and an active impetiginized skin lesion; Atopic dermatitis group: dermatologist-confirmed atopic dermatitis and an active impetiginized skin lesion; Healthy control group: no inflammatory skin disease or clinical signs of infection; Written informed consent (and appropriate parent/guardian permission when applicable).
Exclusion: Systemic or topical antibiotic use within the previous 14 days; Active nasal infection or nasal symptoms; History of nasal surgery or anatomic nasal deformity; TEST DRAFT NOTE: The source protocol contains wording that may conflict with inclusion of healthy controls; the final eligibility text must be reconciled with the ethics-approved protocol before release.